Finance

Beta
Lists
DARE:NASDAQ
Dare Bioscience Inc
$2.09
-0.95%
(-0.020) 1D
$2.06
-1.44% (-0.030)
After hours
Closed: Jul 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DARE...
Open
$2.13
High
$2.20
Low
$2.06
Mkt. cap
31.31M
Avg. vol.
210.13K
Volume
124.08K
52-wk high
$9.19
52-wk low
$1.27
EPS
-$1.04
Beta
1.03
Shares outstanding
14.98M
No. of employees
21
Open
$2.13
High
$2.20
Low
$2.06
Mkt. cap
31.31M
Avg. vol.
210.13K
Volume
124.08K
52-wk high
$9.19
52-wk low
$1.27
EPS
-$1.04
Beta
1.03
Shares outstanding
14.98M
No. of employees
21
News stories
From sources across the web
About Dare Bioscience Inc
CEOSabrina Martucci Johnson
Employees21
Founded2005
HeadquartersSan Diego, California, United States
SectorPharmaceutical industry
Websitedarebioscience.com
Analyst ratings
Based on 2 analysts giving stock ratings to DARE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for DARE in the last 3 months.
Highest
Current $2.09
$12.00 (+474.16%)
Average
$10.00 (+378.47%)
Lowest
$8.00 (+282.78%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$8.00
+282.8%
05/18/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$12.00
+474.2%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-21.17K
2.26K
1.02M
152.46K
Cost of goods sold
-
1.18M
-4.61M
902.79K
Cost of revenue
-
1.18M
-4.61M
902.79K
Research and development expenses
1.43M
-
5.52M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.38M
2.50M
1.58M
2.25M
Operating expense
3.81M
2.50M
7.10M
2.25M
Total operating expenses
3.81M
3.67M
2.49M
3.15M
Operating income
-3.83M
-3.67M
-1.47M
-3.00M
Other non operating income
-188.68K
109.38K
29.55K
-991.00
EBT including unusual items
-4.02M
-3.56M
-1.44M
-3.00M
EBT excluding unusual items
-4.02M
-3.56M
-1.44M
-3.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.02M
-3.56M
-1.44M
-3.00M
Net profit margin
18,970.73%
-157,505.13%
-140.84%
-1,967.72%
Earnings per share
-0.45
-0.28
-0.10
-0.20
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.37M
-3.19M
-936.87K
-2.44M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer